Načítá se...
Optimizing Treatment of Chronic Lymphocytic Leukemia
During JADPRO Live Virtual 2020, Sandra Kurtin, PhD, ANP-C, AOCN®, described personalization of the treatment of chronic lymphocytic leukemia (CLL) using molecular attributes of the disease, as well as patient characteristics. Dr. Kurtin discussed front-line treatment in previously untreated patient...
Uloženo v:
| Vydáno v: | J Adv Pract Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Harborside Press LLC
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087240/ https://ncbi.nlm.nih.gov/pubmed/34084585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.3.23 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|